Vergoeding 2020-2024 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine (Imipramin ®) | 159.910 | 404.590 | 686.300 | 630.990 | 182.540 |
| N06AA04 Clomipramine (Anafranil ®) | 1.151.800 | 1.138.500 | 1.221.900 | 1.201.100 | 1.941.200 |
| N06AA09 Amitriptyline | 2.965.900 | 2.817.200 | 2.948.100 | 2.876.600 | 3.505.000 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.548.900 | 3.643.600 | 3.949.800 | 4.235.800 | 4.108.300 |
| N06AA12 Doxepine | 20.838 | 274 | 48 | 14 | . |
| N06AA16 Dosulepine (Prothiaden ®) | 53.374 | 55.440 | 52.979 | 49.945 | 52.733 |
| N06AA21 Maprotiline | 64.993 | 66.575 | 41.164 | 36.543 | 27.526 |
| Totaal | 7.965.715 | 8.126.179 | 8.900.291 | 9.030.992 | 9.817.299 |